(VIANEWS) – Horizon Technology Finance Corporation (HRZN), Imax Corporation (IMAX), Intuitive Surgical (ISRG) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Horizon Technology Finance Corporation (HRZN)
23.1% sales growth and 4.79% return on equity
Horizon Technology Finance Corporation is a business development company specializing in lending and and investing in development-stage investments. It focuses on making secured debt and venture lending investments to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries. It seeks to invest in companies in the United States.
Earnings Per Share
As for profitability, Horizon Technology Finance Corporation has a trailing twelve months EPS of $0.57.
PE Ratio
Horizon Technology Finance Corporation has a trailing twelve months price to earnings ratio of 20.6. Meaning, the purchaser of the share is investing $20.6 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.79%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 51.3%, now sitting on 102.55M for the twelve trailing months.
Volume
Today’s last reported volume for Horizon Technology Finance Corporation is 131953 which is 50.75% below its average volume of 267954.
2. Imax Corporation (IMAX)
16.8% sales growth and 3.18% return on equity
IMAX Corporation, together with its subsidiaries, operates as an entertainment technology company that specializes in digital and film-based motion picture technologies worldwide. It offers cinematic solution comprising proprietary software, theater architecture, intellectual property, and equipment. The company offers Digital Re-Mastering (DMR), a proprietary technology that digitally enhances the image resolution, visual clarity, and sound quality of motion picture films for projection on IMAX screens; IMAX premium theater systems to exhibitor customers through sales, long-term leases, and joint revenue sharing arrangements; film post-production services; and camera and other miscellaneous items rental services, as well as distributes documentary films; and owns and operates IMAX theaters. It also designs, manufactures, installs, sells, and leases IMAX theater projection system equipment; maintains IMAX theater projection system equipment in the IMAX theater network; distributes and licenses original content, virtual reality, IMAX home entertainment, and others; and sells or leases its theater systems to theme parks, private home theaters, tourist destination sites, fairs, and expositions, as well as engages in the after-market sale of projection system parts and 3D glasses. The company markets its theater systems through a direct sales force and marketing staff. It owns or otherwise has rights to trademarks and trade names, which include IMAX, IMAX Dome, IMAX 3D, IMAX 3D Dome, Experience It in IMAX, The IMAX Experience, An IMAX Experience, An IMAX 3D Experience, IMAX DMR, DMR, IMAX nXos, and Films To The Fullest. As of March 31, 2020, the company had a network of 1,616 IMAX theater systems comprising 1,526 commercial multiplexes, 14 commercial destinations, and 76 institutional facilities operating in 81 countries and territories. IMAX Corporation was founded in 1967 and is headquartered in Mississauga, Canada.
Earnings Per Share
As for profitability, Imax Corporation has a trailing twelve months EPS of $0.08.
PE Ratio
Imax Corporation has a trailing twelve months price to earnings ratio of 237.38. Meaning, the purchaser of the share is investing $237.38 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.18%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Imax Corporation’s EBITDA is 3.41.
Yearly Top and Bottom Value
Imax Corporation’s stock is valued at $18.99 at 01:22 EST, way below its 52-week high of $21.82 and way higher than its 52-week low of $12.13.
Sales Growth
Imax Corporation’s sales growth is 30.4% for the present quarter and 16.8% for the next.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 380% and 57.9%, respectively.
3. Intuitive Surgical (ISRG)
15.7% sales growth and 12.05% return on equity
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Earnings Per Share
As for profitability, Intuitive Surgical has a trailing twelve months EPS of $4.01.
PE Ratio
Intuitive Surgical has a trailing twelve months price to earnings ratio of 73.8. Meaning, the purchaser of the share is investing $73.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.05%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 18.5% and 22.8%, respectively.
Yearly Top and Bottom Value
Intuitive Surgical’s stock is valued at $295.92 at 01:22 EST, way below its 52-week high of $358.07 and way higher than its 52-week low of $180.07.
Previous days news about Intuitive Surgical(ISRG)
- According to Zacks on Friday, 15 September, "Long-term earnings growth rates for Intuitive Surgical and Option Care Health are pegged at 15.7% and 20.24%, respectively."
4. Qualys (QLYS)
10.9% sales growth and 35.76% return on equity
Qualys, Inc. provides cloud-based information technology (IT), security, and compliance solutions in the United States and internationally. The company offers Qualys Cloud Apps, which includes Vulnerability Management; Vulnerability Management, Detection and Response; Threat Protection; Continuous Monitoring; Patch Management; Multi-Vector Endpoint Detection and Response; Certificate Assessment; SaaS Detection and Response; Secure Enterprise Mobility; Policy Compliance; Security Configuration Assessment; PCI Compliance; File Integrity Monitoring; Security Assessment Questionnaire; Out of-Band Configuration Assessment; Web Application Scanning; Web Application Firewall; Global Asset Inventory; Cybersecurity Asset Management; Certificate Inventory; Cloud Inventory; Cloud Security Assessment; and Container Security. Its integrated suite of IT, security, and compliance solutions delivered on its Qualys Cloud Platform enables customers to identify and manage IT assets, collect and analyze IT security data, discover and prioritize vulnerabilities, recommend and implement remediation actions, and verify the implementation of such actions. The company also provides asset tagging and management, reporting and dashboards, questionnaires and collaboration, remediation and workflow, big data correlation and analytics engine, and alerts and notifications, which enable integrated workflows, management and real-time analysis, and reporting across IT, security, and compliance solutions. The company offers its solutions through its sales teams, as well as through its network of channel partners, such as security consulting organizations, managed service providers, resellers, and consulting firms. It serves enterprises, government entities, and small and medium-sized businesses in various industries, including education, financial services, government, healthcare, insurance, manufacturing, media, retail, technology, and utilities. The company was incorporated in 1999 and is headquartered in Foster City, California.
Earnings Per Share
As for profitability, Qualys has a trailing twelve months EPS of $3.19.
PE Ratio
Qualys has a trailing twelve months price to earnings ratio of 48.69. Meaning, the purchaser of the share is investing $48.69 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 35.76%.
Sales Growth
Qualys’s sales growth is 12.9% for the current quarter and 10.9% for the next.
5. Antero Midstream Partners LP (AM)
9.1% sales growth and 15.53% return on equity
Antero Midstream Corporation owns and operates midstream energy assets. It owns and operates natural gas gathering pipelines, compression stations, processing and fractionation plants, and water handling and treatment assets in the Marcellus Shale and Utica Shale basins. The company was founded in 2013 and is headquartered in Denver, Colorado.
Earnings Per Share
As for profitability, Antero Midstream Partners LP has a trailing twelve months EPS of $0.71.
PE Ratio
Antero Midstream Partners LP has a trailing twelve months price to earnings ratio of 17.18. Meaning, the purchaser of the share is investing $17.18 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.53%.
6. Semler Scientific (SMLR)
5.1% sales growth and 30.6% return on equity
Semler Scientific, Inc. develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.
Earnings Per Share
As for profitability, Semler Scientific has a trailing twelve months EPS of $2.33.
PE Ratio
Semler Scientific has a trailing twelve months price to earnings ratio of 12.04. Meaning, the purchaser of the share is investing $12.04 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 30.6%.
Sales Growth
Semler Scientific’s sales growth is 8.2% for the present quarter and 5.1% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Semler Scientific’s EBITDA is 2.18.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 10.9% and 14.6%, respectively.
